These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 27487997)
61. The Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships. Odevall L; Hong D; Digilio L; Sahastrabuddhe S; Mogasale V; Baik Y; Choi S; Kim JH; Lynch J Vaccine; 2018 Oct; 36(45):6606-6614. PubMed ID: 30314912 [TBL] [Abstract][Full Text] [Related]
63. Immunogenicity of liposome-associated oral cholera vaccine prepared from combined Vibrio cholerae antigens. Chaicumpa W; Parairo JR; New RC; Pongponratn E; Ruangkunaporn Y; Tapchaisri P; Chongsa-nguan M Asian Pac J Allergy Immunol; 1990 Dec; 8(2):87-94. PubMed ID: 2091663 [TBL] [Abstract][Full Text] [Related]
64. Cholera in Yemen. Balakrishnan VS Lancet Infect Dis; 2017 Jul; 17(7):700-701. PubMed ID: 28737493 [No Abstract] [Full Text] [Related]
65. USE OF VIBRIO CHOLERAE SURFACE STRUCTURES FOR SPECIFIC PROPHY- LAXIS AND DIAGNOSTICS OF CHOLERA. Ivanova LA; Mishankin BN; Bespalova IA; Omelchenko ND; Shipko ES; Filippenko AV Zh Mikrobiol Epidemiol Immunobiol; 2017 Mar; (2):110-115. PubMed ID: 30695546 [TBL] [Abstract][Full Text] [Related]
66. Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants. Kashima K; Yuki Y; Mejima M; Kurokawa S; Suzuki Y; Minakawa S; Takeyama N; Fukuyama Y; Azegami T; Tanimoto T; Kuroda M; Tamura M; Gomi Y; Kiyono H Plant Cell Rep; 2016 Mar; 35(3):667-79. PubMed ID: 26661780 [TBL] [Abstract][Full Text] [Related]
67. Oral cholera vaccine development and use in Vietnam. Anh DD; Lopez AL; Tran HT; Cuong NV; Thiem VD; Ali M; Deen JL; von Seidlein L; Sack DA PLoS Med; 2014 Sep; 11(9):e1001712. PubMed ID: 25180511 [TBL] [Abstract][Full Text] [Related]
68. Cholera in Yemen: war, hunger, disease…and heroics. The Lancet Infectious Diseases Lancet Infect Dis; 2017 Aug; 17(8):781. PubMed ID: 28741538 [No Abstract] [Full Text] [Related]
69. A Novel Luminescence-Based Serum Bactericidal Assay for Vibrio cholerae Reduces Assay Variation, Is Time- and Cost-Effective, and Directly Measures Continuous Titer Values. Wahlig TA; Brintz BJ; Prettyman M; Azman AS; Leung DT Am J Trop Med Hyg; 2021 Jul; 105(3):622-626. PubMed ID: 34237020 [TBL] [Abstract][Full Text] [Related]
70. Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India. Kar SK; Pach A; Sah B; Kerketta AS; Patnaik B; Mogasale V; Kim YH; Rath SB; Shin S; Khuntia HK; Bhattachan A; Puri MK; Wierzba TF; Kaljee LM Hum Vaccin Immunother; 2014; 10(10):2834-42. PubMed ID: 25483631 [TBL] [Abstract][Full Text] [Related]
72. From the National Institute of Allergy and Infectious Diseases. Summary of the 21st United States-Japan Joint Cholera Conference. Edelman R; Sack RB J Infect Dis; 1986 Aug; 154(2):377-80. PubMed ID: 3722875 [No Abstract] [Full Text] [Related]
73. The use of cholera oral vaccine for containment of the 2019 disease outbreak in Sudan. Mohamed NS; Ali Y; Abdalrahman S; Ahmed A; Siddig EE Trans R Soc Trop Med Hyg; 2022 Sep; 116(9):763-766. PubMed ID: 35537855 [TBL] [Abstract][Full Text] [Related]
76. Not one but four possible oral vaccines for cholera under study. Henahan J JAMA; 1982 Oct; 248(16):1937-8. PubMed ID: 7120612 [No Abstract] [Full Text] [Related]
79. Towards cholera elimination in Zanzibar: analysis of evidences on what have worked. Redae GA; Mengestu TK; Abdalla FM; Slim SN; Simon VT; Ali AO; Saguti GE; Habtu MM; Tegegne SG; Msambazi MJ; Zabulon Y Pan Afr Med J; 2023; 45(Suppl 1):6. PubMed ID: 37538360 [TBL] [Abstract][Full Text] [Related]
80. Pathways to a policy for cholera control in India. Sekhar A; Kang G Vaccine; 2020 Feb; 38 Suppl 1():A157-A159. PubMed ID: 31266672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]